Literature DB >> 20525890

CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.

Lydia A Haile1, Jaba Gamrekelashvili, Michael P Manns, Firouzeh Korangy, Tim F Greten.   

Abstract

Myeloid-derived suppressor cells (MDSCs) are a heterogenous population of cells that negatively regulate the immune response during tumor progression, inflammation, and infection. In this study, through gene-expression analysis, we have identified a new marker, CD49d, which is expressed exclusively on CD11b(+)Gr-1(dull/int.) MDSCs. We have characterized two subpopulations of MDSCs based on CD49d expression in two different settings, a mouse model of inflammatory bowel disease and tumor-bearing mice. The CD49d(+) subset of MDSCs was mainly monocytic and strongly suppressed Ag-specific T cell proliferation in an NO-dependent mechanism similar to Gr-1(dull/int.) MDSCs. Alternatively, CD49d(-) cells were granulocytic and poorly inhibited T cell proliferation compared with CD11b(+)Gr-1(high) cells. Both mouse models showed preferential expansion of the granulocytic CD49d(-) subset. We suggest that CD49d can be used as an alternative marker for Gr-1 to differentiate between the subpopulations of MDSCs together with CD11b, which will ultimately help in understanding the mechanisms of immune suppression by MDSCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20525890     DOI: 10.4049/jimmunol.0903573

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

Review 1.  Myeloid-derived suppressor cells in transplantation and cancer.

Authors:  Jordi C Ochando; Shu Hsia Chen
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

2.  S100A9 a new marker for monocytic human myeloid-derived suppressor cells.

Authors:  Fei Zhao; Bastian Hoechst; Austin Duffy; Jaba Gamrekelashvili; Suzanne Fioravanti; Michael P Manns; Tim F Greten; Firouzeh Korangy
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

Review 3.  Phenotype, development, and biological function of myeloid-derived suppressor cells.

Authors:  Yang Zhao; Tingting Wu; Steven Shao; Bingyi Shi; Yong Zhao
Journal:  Oncoimmunology       Date:  2015-10-14       Impact factor: 8.110

Review 4.  MDSC in autoimmunity.

Authors:  James G Cripps; James D Gorham
Journal:  Int Immunopharmacol       Date:  2011-02-21       Impact factor: 4.932

5.  Does CSF1R Blockade Turn into Friendly Fire?

Authors:  Tim F Greten
Journal:  Cancer Cell       Date:  2017-11-13       Impact factor: 31.743

6.  Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans.

Authors:  Gerhard Wingender; Marcus Hiss; Isaac Engel; Konrad Peukert; Klaus Ley; Hermann Haller; Mitchell Kronenberg; Sibylle von Vietinghoff
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

7.  IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.

Authors:  José Medina-Echeverz; Lydia A Haile; Fei Zhao; Jaba Gamrekelashvili; Chi Ma; Jean-Yves Métais; Cynthia E Dunbar; Veena Kapoor; Michael P Manns; Firouzeh Korangy; Tim F Greten
Journal:  Eur J Immunol       Date:  2014-06-16       Impact factor: 5.532

8.  Deficiency of KLF4 compromises the lung function in an acute mouse model of allergic asthma.

Authors:  Jeanette A Nimpong; Wintana Gebregziabher; Udai P Singh; Prakash Nagarkatti; Mitzi Nagarkatti; Johnie Hodge; Chunming Liu; Daping Fan; Walden Ai
Journal:  Biochem Biophys Res Commun       Date:  2017-09-01       Impact factor: 3.575

9.  Peptide-based systems analysis of inflammation induced myeloid-derived suppressor cells reveals diverse signaling pathways.

Authors:  Waeowalee Choksawangkarn; Lauren M Graham; Meghan Burke; Sang Bok Lee; Suzanne Ostrand-Rosenberg; Catherine Fenselau; Nathan J Edwards
Journal:  Proteomics       Date:  2016-07       Impact factor: 3.984

10.  Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice.

Authors:  Chi Ma; Tamar Kapanadze; Jaba Gamrekelashvili; Michael P Manns; Firouzeh Korangy; Tim F Greten
Journal:  J Leukoc Biol       Date:  2012-10-17       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.